![]() ![]() ![]() ![]() He adds, We also see an opportunity to integrate IRISs cell imaging capability and hematology products under development into our Hematology product roadmap. By leveraging Beckman Coulters strong commercial infrastructure, IRIS can extend the reach and market share of its products in every geography around the globe. Outstanding reputation in both automated and semi-automated urinalysis products. (NASDAQ: IRIS) pursuant to which Beckman Coulter will acquire IRIS for $19.50 per share in cash.Ĭoulters President and Danaher Executive Vice President Tom Joyce said, IRIS provides an excellent complement to Beckman Coulters diagnostics business, as we continue serving the needs of the hospital laboratory. Beckman Coulter announced today that Danaher Corporation and a wholly-owned subsidiary of Beckman Coulter have entered into a definitive merger agreement ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |